Robert A. Weinberg to Deliver a Keynote Address at GTCbios 2nd International Conference on Tumor Progression & Therapeutic Resistance

Robert A. Weinberg will be delivering the Keynote address at an upcoming confernce on Tumor Progression & Therapeutic Resistance being held by GTCbio. This years conference is sponsored in part by Abramson Cancer Center at the University of Pennsylvania, GlaxoSmithKline, Merck Research Laboratories Boston, Pfizer, Landes Bioscience and Cancer Cell.

MONROVIA (PRWEB) August 28, 2005 -- GTCbio today announced that Robert A. Weinberg, Professor for Cancer Research at MIT, will be presenting the Keynote Address at this years Tumor Progression & Therapeutic Resistance Conference. The conference is being held September 18--20, 2005 at the Boston Marriott Burlington in Burlington, Massachusetts.

Dr. Weinberg is a founding member of the Whitehead Institute and is most well known as a pioneer in cancer research. He has received several prestigious awards throughout his career, including the National Medal of Science in 1997 and the Wolf Prize in Medicine in 2004. His presentation, entitled Mechanisms of Formation of Human Malignant Tumors", will take place as part of the Opening Ceremonies on September 18.

The 3 day event will also feature speakers from Childrens Hospital of Boston, Columbia University, Dana Farber Cancer Institute, Harvard University, Incyte Corportation, Johns Hopkins University, the National Cancer Institute-NIH, Pfizer, Schering-Plough, UCSF along with many other esteemed universities.

This years conference is sponsored in part by Abramson Cancer Center at the University of Pennsylvania, GlaxoSmithKline, Merck Research Laboratories Boston, Pfizer, Landes Bioscience and Cancer Cell.

More information including a detailed agenda, exhibitor opportunities and registration information can be found at http://www.gtcbio.com/confpage.asp?cid=17.

About GTCbio:
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax

###